check_circleStudy Completed

Magnetic Resonance Imaging, Liver Neoplasms

Study to evaluate the diagnostic efficacy of Gd-EOB-DTPA in the characterization of focal liver lesions

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
235
Trial Dates
April 2000 - July 2001
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A multi-center (US) open-label study of Gd-EOB-DTPA with a single intravenous injection (25 μmol/kg body weight) in patients with known or suspected focal liver lesions and the corresponding blinded reading to evaluate the diagnostic efficacy of Gd-EOB-DTPA in the characterization of focal liver lesions
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A